27 June 2022 - PHARMAC today announced that it is permanently widening access to the annual funded flu vaccine to people ...
16 May 2022 - The EUA authorises at home sample collection with testing performed in a laboratory. ...
8 April 2022 - PHARMAC is being accused of kicking an own goal on flu jabs, after those aged 65 ...
28 March 2022 - Seqirus announced today that it has received Health Canada approval of Flucelvax Quad (influenza vaccine), its cell-based ...
25 March 2022 - The Australian Influenza Vaccine Committee has reviewed data related to epidemiology, antigenic and genetic characteristics of recent ...
18 March 2022 - Leading health care provider ProCare has today made a submission in support of PHARMAC’s proposal to ...
8 March 2022 - PHARMAC is consulting on a proposal to widen access to the funded influenza vaccine to include Māori ...
1 March 2022 - PHARMAC has confirmed that the purchase price of the annual influenza vaccine will increase by $2 ...
28 June 2021 - EMA has issued an update of the EU recommendations for the influenza virus strains that vaccine ...
27 April 2021 - A war has broken out between chemists and doctors, who say elderly Australians are being given an ...
23 March 2021 - Health Canada's approval of Foclivia (an adjuvanted, egg-based A strain H5N1 pandemic influenza vaccine) meets key requirement ...
24 March 2021 - A new type of cell-based influenza vaccine is available this winter that promises to be significantly ...
16 February 2021 - Australians are being advised to wait two weeks between getting the flu jab and COVID-19 vaccine ...
22 September 2020 - Positive opinion based on clinical data demonstrating safety and efficacy of Supemtek for adults aged 18 and ...
9 September 2020 - As its brand name suggests, Flucelvax Quad is a new quadrivalent influenza vaccine. ...